Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Lass

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Acta Neuropathologica|January 26, 2005
Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomasWolf Mueller, Ulrike Lass, Sven Wellmann, et al.
Brain Pathology (Zurich, Switzerland)|April 15, 2006
45-year-old male with symptomatic mass in the frontal lobeWolf Mueller, Ulrike Lass, Julian Veelken, et al.
Journal of Neuropathology and Experimental Neurology|February 18, 2005
Molecular genetic analysis of oligodendroglial tumorsChristian Hartmann, Wolf Mueller, Ulrike Lass, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 28, 2004
Somatic mutations in peroxisome proliferator-activated receptor-gamma are rare events in human cancer cellsMaximilian G Posch, Chuanbing Zang, Wolf Mueller, et al.
Brain Pathology (Zurich, Switzerland)|October 31, 2012
Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomasUlrike Lass, Christian Hartmann, David Capper, et al.
Brain Pathology (Zurich, Switzerland)|July 12, 2008
RASSF1A, BLU, NORE1A, PTEN and MGMT expression and promoter methylation in gliomas and glioma cell lines and evidence of deregulated expression of de novo DNMTsAiala Lorente, Wolf Mueller, Edurne Urdangarín, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomasAgnes Elias, Markus D Siegelin, Albert Steinmüller, et al.
International Journal of Cancer|February 13, 2004
No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytomaGesche Tallen, Ines Kaiser, Sonja Krabbe, et al.
Aesthetic Plastic Surgery|December 17, 2013
Pulsed acoustic cellular expression (PACE) reduces capsule formation around silicone implantsMatthias A Reichenberger, Sina Heimer, Ulrike Lass, et al.
Microsurgery|December 31, 2015
ADSCs in a fibrin matrix enhance nerve regeneration after epineural suturing in a rat modelMatthias A Reichenberger, Wolf Mueller, Jennifer Hartmann, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Acta Neuropathologica|January 26, 2005
Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomasWolf Mueller, Ulrike Lass, Sven Wellmann, et al.
Brain Pathology (Zurich, Switzerland)|April 15, 2006
45-year-old male with symptomatic mass in the frontal lobeWolf Mueller, Ulrike Lass, Julian Veelken, et al.
Journal of Neuropathology and Experimental Neurology|February 18, 2005
Molecular genetic analysis of oligodendroglial tumorsChristian Hartmann, Wolf Mueller, Ulrike Lass, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 28, 2004
Somatic mutations in peroxisome proliferator-activated receptor-gamma are rare events in human cancer cellsMaximilian G Posch, Chuanbing Zang, Wolf Mueller, et al.
Brain Pathology (Zurich, Switzerland)|October 31, 2012
Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomasUlrike Lass, Christian Hartmann, David Capper, et al.
Brain Pathology (Zurich, Switzerland)|July 12, 2008
RASSF1A, BLU, NORE1A, PTEN and MGMT expression and promoter methylation in gliomas and glioma cell lines and evidence of deregulated expression of de novo DNMTsAiala Lorente, Wolf Mueller, Edurne Urdangarín, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomasAgnes Elias, Markus D Siegelin, Albert Steinmüller, et al.
International Journal of Cancer|February 13, 2004
No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytomaGesche Tallen, Ines Kaiser, Sonja Krabbe, et al.
Aesthetic Plastic Surgery|December 17, 2013
Pulsed acoustic cellular expression (PACE) reduces capsule formation around silicone implantsMatthias A Reichenberger, Sina Heimer, Ulrike Lass, et al.
Microsurgery|December 31, 2015
ADSCs in a fibrin matrix enhance nerve regeneration after epineural suturing in a rat modelMatthias A Reichenberger, Wolf Mueller, Jennifer Hartmann, et al.
Pageof 2